Chromothripsis and ecDNA initiated by N4BP2 nuclease fragmentation of cytoplasm-exposed chromosomes
Science · 11.12.2025 · 390 (6778) · 1156-1163
DOI: 10.1126/science.ado0977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 11.12.2025. Verfasst von Ksenia Krupina und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, USA. Hauptthemen laut MEDLINE: Chromothripsis, Cytoplasm, DNA Fragmentation, DNA Repair Enzymes. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS, Wellcome Trust.
Abstract (Originalsprache)
Genome instability, including chromothripsis, is a hallmark of cancer. Cancer cells frequently contain micronuclei—small, nucleus-like structures formed by chromosome missegregation—that are susceptible to rupture, exposing chromatin to cytoplasmic nucleases. Through an unbiased, imaging-based small interfering RNA screen that targeted all 204 known and putative human nucleases, we identified a previously uncharacterized cytoplasmic endonuclease, NEDD4-binding protein 2 (N4BP2), that enters ruptured micronuclei and initiates DNA damage, leading to chromosome fragmentation. N4BP2 promoted genome rearrangements (including chromothripsis), formation of extrachromosomal DNA (ecDNA) in drug-induced gene amplification, tumorigenesis, and tumor cell proliferation in an induced model of human high-grade glioma. Analysis of more than 10,000 human cancer genomes revealed elevated N4BP2 expression to be predictive of chromothripsis and copy number amplifications, including ecDNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, USA.
- Department of Bioengineering, University of California at San Diego, La Jolla, USA.
- Moores Cancer Center, University of California at San Diego, La Jolla, USA.
- Department of Haematology, University of Cambridge, Cambridge, UK.
- Wellcome Trust Sanger Center, Hinxton, UK.
- Department of Cell and Developmental Biology, University of California at San Diego, La Jolla, USA.
ORCID-Profile: Ksenia Krupina, Alexander Goginashvili, Michael W Baughn, Stephen Moore, Christopher D Steele, Daniel L Zhang, Jonas Koeppel, Prasad Trivedi, David Jenkins, Tomoyuki Koga, Shunichiro Miki, Frank B Furnari, Peter J Campbell, Ludmil B Alexandrov, Don W Cleveland
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- Wellcome Trust
- NIGMS NIH HHS
- NIEHS NIH HHS
- National Institutes of Health
- Wellcome
- Hope Funds for Cancer Research
Zitieren
APA
Krupina, K., Goginashvili, A., Baughn, M. W., Moore, S., Steele, C. D., Nguyen, A. T., Zhang, D. L., Koeppel, J., Trivedi, P., Malhotra, A., Jenkins, D., Shiau, A. K., Miyake, Y., Koga, T., Miki, S., Furnari, F. B., Campbell, P. J., Alexandrov, L. B., & Cleveland, D. W. (2025). Chromothripsis and ecDNA initiated by N4BP2 nuclease fragmentation of cytoplasm-exposed chromosomes. Science, 390(6778), 1156-1163. https://doi.org/10.1126/science.ado0977
Vancouver
Krupina K, Goginashvili A, Baughn MW, Moore S, Steele CD, Nguyen AT, et al. Chromothripsis and ecDNA initiated by N4BP2 nuclease fragmentation of cytoplasm-exposed chromosomes. Science. 2025;390(6778):1156-1163. doi:10.1126/science.ado0977
BibTeX
@article{Krupina2025,
author = {Krupina, Ksenia and Goginashvili, Alexander and Baughn, Michael W and Moore, Stephen and Steele, Christopher D and Nguyen, Amy T and Zhang, Daniel L and Koeppel, Jonas and Trivedi, Prasad and Malhotra, Aarti and Jenkins, David and Shiau, Andrew K and Miyake, Yohei and Koga, Tomoyuki and Miki, Shunichiro and Furnari, Frank B and Campbell, Peter J and Alexandrov, Ludmil B and Cleveland, Don W},
title = {Chromothripsis and ecDNA initiated by N4BP2 nuclease fragmentation of cytoplasm-exposed chromosomes},
journal = {Science},
year = {2025},
volume = {390},
number = {6778},
pages = {1156--1163},
doi = {10.1126/science.ado0977}
}
EUVIMED